News Daily News ORBITA Redux: Lancet Correspondence Takes Talk of the Sham-Controlled PCI Trial to Further Heights Michael O'Riordan July 10, 2018
News Daily News ‘High Index of Suspicion’ First Step in Successful Management of SCAD Michael O'Riordan February 27, 2018